Catalyst Wire Dossier Catalyst Wire Dossier

PanCytoVir oral suspension

· TrippBio, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PanCytoVir oral suspension, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Relative Bioavailability Study With a Novel PanCytoVir™ Oral Suspension (100 mg/ml) [Phase 1]

See pricing